PATENT EXPIRATION TO CUT PRICES

INDIANAPOLIS -- A recent federal appeals court ruling allows generic competition for the antidepressant drug Prozac, produced by Eli Lilly & Co. here., and many other prescriptions drugs are expected lose their patent protection in coming years, which would trigger lower prices for an array of medications, observers noted.omising cheaper, generic prices and increasing government pressure on drug-makers

INDIANAPOLIS -- A recent federal appeals court ruling allows generic competition for the antidepressant drug Prozac, produced by Eli Lilly & Co. here., and many other prescriptions drugs are expected lose their patent protection in coming years, which would trigger lower prices for an array of medications, observers noted.

omising cheaper, generic prices and increasing government pressure on drug-makers for more inexpensive medications, according to press reports.

"The cos

Register to view the full article

test - Advanced Registered User

Already a member? .